ArticleEndocrine2023

Add-on radioiodine during long-term BRAF/MEK inhibition in patients with RAI-refractory thyroid cancers: a reasonable option?

Filipe Miguel Montes de Jesus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.